NAUT Nautilus Biotechnology, Inc.
USHealthcareAs of 2026-07-08 16:00
Why NAUT matters now
Nautilus Biotechnology, Inc. (NAUT) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.78 with +5.33% on the session and $226.2M in market capitalization; recent performance reads 1-month -4.20% and YTD +16.92%.
The latest financial table shown here is Q1 2026, with revenue of $0.00, net income of $-14.7M, and EPS of $-0.12. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -17.7%.
The latest indexable market news headline is "Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $2.50; recent insider activity includes AH Equity Partners Bio II, L.L.C. filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
2.00
P/S
0.00
EV/EBITDA
-5.99
DCF Value
$-0.15
FCF Yield
-17.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-35.0%
ROA
-32.1%
ROIC
-37.0%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $0.00 | $-14.7M | $-0.12 |
| Q4 2025 | $0.00 | $-13.8M | $-0.11 |
| FY 2025 | $0.00 | $-59.0M | $-0.47 |
| Q3 2025 | $0.00 | $-13.6M | $-0.11 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$2.50
Target (Median)
$2.50
Target Range
$2.50 - $2.50
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
—
Beta
0.75
Nautilus Biotechnology, Inc. is an emerging life sciences firm dedicated to pioneering a platform technology aimed at quantifying and comprehensively understanding the intricate complexities of the proteome. Their flagship offering, the Nautilus Platform, is an integrated proteomics system. It provides a complete, end-to-end solution, including specialized instruments, essential consumables, and advanced software for data analysis. Based in Seattle, Washington, the company was established in 2016.